News
Bonn, 29. January, 2014
Drug Response Dx GmbH is presenting at the Theragnostics-Workshop of the High-Tech Partnering Conference
Drug Response Dx GmbH is presenting at the Theragnostics-Workshop of the High-Tech Partnering Conference am 29. January 2014 in Bonn, Germany. For more information on the conference please visit the site of the High-Tech Gründerfond:
→ more (in German)Dubai, 27. – 30. January, 2014
The Drug Response Dx GmbH is represented on the Arab Health 2014
The Drug Response Dx GmbH is represented on the Arab Health 2014 at the Dubai International Convention & Exhibition Centre. Come and see us at the DiagnostikNet BB e.V. stand (Rashid Hall, RJ14) and ask for Dr. Jörg-M. Hollidt.
For more Information see:→ Dubai International Convention & Exhibition Centre
Bernau, May 22.-23., 2013
Dr. Zoltán Konthur presents Individualized Therapies in Rheumatoid Arthritis at the “15. Bernauer Autoimmuntage” in Bernau, Germany.
Hennigsdorf / Bonn / Hilden, January 7, 2013
Drug Rsponse Dx attracts first investment
The Hennigsdorf firm Drug Response Dx GmbH (DRDx GmbH) successfully concluded its first round of financing with High-Tech Gründerfonds and QIAGEN.
The investment will serve to develop a biomarker test kit for rheumatoid arthritis treatment guidance with so-called TNF-alpha inhibitors. The test is secured by a unique patent platform exclusively in-licensed by the Max Planck Society.